7 Ergebnisse
This application is a 371 of PCT/lL02/00800, filed on 2 Oct. 2002.
The present invention relates to compositions for the treatment of pilosebaceous gland inflammations, especially of the hair follicle and its appendages, in particular of Acne Vulgaris and Folliculitis. Said compositions have, inter
FIELD OF THE INVENTION
This invention relates generally to compositions and methods useful in the prevention and treatment of osteoporosis and for bone and fracture repair. More specifically, the invention relates to slow-releasing calcium phosphate-based materials incorporating Mg, Zn, F, carbonate
BACKGROUND OF THE INVENTION
The present invention relates generally to composition and method for the preventative treatment of the initiation and progression of bacterially-induced, dental disease including periodontal disease and apparatus for dispensing said composition. The composition includes
TECHNICAL FIELD
This invention relates generally to the field of treating dental conditions, particularly caries, and more particularly to methods, compositions and devices that promote in vivo regeneration and remineralization of dentin and enamel by inserting tissue scaffold materials in vivo,
TECHNICAL FIELD
The present disclosure generally relates to mouthwash compositions and, more particularly, to non-alcohol mouthwash compositions.
BACKGROUND
As the mouth cavity is in frequent contact with food, bacteria develops therein which must be addressed with good oral hygiene to reduce the
FIELD OF THE INVENTION
The present invention consists of a pharmaceutical composition for oral use, of antiseptic action, of broad spectrum in the form of a mouth wash or other forms of presentation, which are useful to prevent or cure oral illnesses originated by germs.
The vast majority of oral
FIELD OF INVENTION
The present invention is directed towards a new method of synthesis of .sup.18F-labeled pteroate or folate radiopharmaceuticals, wherein fluorine-18 is attached to a pteroate (or folate) or derivative thereof, through direct radiolabeling with .sup.18[F]fluoride, as well as